Candida clinical species identification: molecular and biochemical methods
Tóm tắt
In the last decade, the number and diversity of nosocomial Candida infections has increased significantly, resulting in an emergent need for rapid and accurate methods for Candida identification. Therefore, the aim of this study was to evaluate the performance of three biochemical systems (Auxacolor, ID32C, and Vitek 2 YST) for the identification of Candida species, comparing them with molecular identification (polymerase chain reaction and gel agarose electrophoresis). These methods were used to assess Candida spp. (229 clinical isolates) prevalence and distribution among clinical specimens. The biochemical methods with higher percentages of correct identification were Vitek 2 YST (79.6%) and Auxacolor (78.6%). However, overall the biochemical methods assayed differed from the molecular identification. Thus, due to their rapid and precise identification, molecular methods are promising techniques for Candida species identification in clinical laboratories. Candida albicans and Non Candida albicans Candida species had a similar prevalence (50.4 and 49.6%, respectively), corroborating the epidemiological shift observed for these pathogens in the recent years.
Tài liệu tham khảo
Abaci Ö, Halki-Huztan A, Ates M (2008) Specific identification of Candida albicans and Candida dubliniensis by PCR using species-specific primers. Ann Microbiol 58:325–331
Beck-Sagué C, Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. Nosocomial Infections Surveillance System. J Infect Dis 167:1247–1251
Campbell CK, Davey KG, Holmes AD, Szekely A, Warnock DW (1999) Comparison of the API Candida system with Auxacolor system for identification of common yeast pathogens. J Clin Microbiol 37:821–823
Crocco EI, Souza VM, Mimica LMJ, Muramatu LH, Garcia C, Ruiz LRB, Zaitz C (2004) Identificação de espécies de Candida e susceptibilidade antifúngica in vitro: estudo de 100 pacientes com candidíases superficiais. An Bras Dermatol 79:689–697
Espinel-Ingroff A, Stockman L, Roberts G, Pincus D, Pollack J, Marler J (1998) Comparison of RapID yeast plus system with API 20C system for identification of common, new, and emerging yeast pathogens. J Clin Microbiol 36:883–886
Fenn JP, Segal H, Barland B, Denton D, Whisenant J, Chun H, Christofferson K, Hamilton L, Carroll K (1994) Comparison of updated Vitek yeast biochemical card and API 20C yeast identification systems. J Clin Microbiol 32:1184–1187
Fleck R, Dietz A, Hof H (2007) In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. J Antimicrob Chemother 59:767–771
Fricker-Hidalgo H, Lebeau B, Kervroedan P, Faure O, Ambroise-Thomas P, Grillot R (1995) Auxacolor, a new commercial system for yeast identification: evaluation of 182 strains comparatively with ID 32 C. Ann Biol Clin 53:221–225
Fridkin SK, Jarvis WR (1996) Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 9:499–511
Goodrich JM, Reed EC, Mori M, Fisher LD, Skerrett S, Dandliker PS, Klis B, Counts GW, Meyers JD (1991) Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J Infect Dis 164:731–740
Goodwin SD, Fiedler-Kelly J, Grasela TH, Schell WA, Perfect JR (1992) A nationwide survey of clinical laboratory methodologies for fungal infections. J Med Vet Mycol 30:153–160
Gutierrez J, Martin E, Lozano C, Coronilla J, Nogales C (1994) Evaluation of the ATB 32 C, automicrobic system and API 20 C using clinical yeast isolates. Ann Biol Clin 50:443–446
Hata DJ, Hall L, Fothergill AW, Larone DH, Wngenack NL (2007) Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identification card. J Clin Microbiol 45:1087–1092
Hazen KC (1995) New and emerging yeast pathogens. Clin Microbiol Rev 8:462–478
Hidalgo JA, Alangaden GJ, Eliott D, Akins RA, Puklin J, Abrams G, Vazquez JA (2000) Fungal endophthalmitis diagnosis by detection of Candida albicans DNA in intraocular fluid by use of a species-specific polymerase chain reaction assay. J Infect Dis 181:1198–1201
Hsu M-C, Chen K-W, Lo H-J, Chen Y-C, Lião M-H, Lin Y-H, Li S-Y (2003) Species identification of medically important fungi by use of real-time LightCycler PCR. J Med Microbiol 52:1071–1076
Huang A, Li J-W, Shen Z-Q, Wang X-W, Jin M (2006) High-throughput identification of clinical pathogenic fungi by hibridization to an oligonucleotide microarray. J Clin Microbiol 44:3299–3305
Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20:1526–1530
Kanbe T, Horii T, Arishima T, Ozeki M, Kikuchi A (2002) PCR-based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes. Yeast 19:973–989
Kanbe T, Arishima T, Horii T, Kikuchi A (2003) Improvements of PCR-based identification targeting the DNA Topoisomerase II gene to determine major species of the opportunistic fungi Candida and Aspergillus fumigatus. Microbiol Immunol 47:631–638
Karlowsky JA, Zhanel GG, Klym KA, Hoban DJ, Kabani AM (1997) Candidemia in a Canadian tertiary care hospital from 1976 to 1996. Diagn Microbiol Infect Dis 28:5–9
Krcmery V, Barnes AJ (2002) Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50:243–260
Kurzai O, Heinz WJ, Sullivan DJ, Coleman DC, Frosch M, Mühlschlegel FA (1999) Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin Microbiol 37:1587–1590
Liguori G, Lucariello A, Colella G, De Luca A, Marinelli P (2007) Rapid identification of Candida species in oral rinse solutions by PCR. J Clin Pathol 60:1035–1039
Loïez C, Wallet F, Sendid B, Courcol RJ (2006) Evaluation of VITEK 2 colorimetric cards versus fluorimetric cards for identification of yeasts. Diagn Microbiol Infect Dis 56:455–457
Marot-Leblond A, Beucher B, David S, Nail-Billaud S, Robert R (2006) Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies. J Clin Microbiol 44:138–142
Nauyen MH, Peacock JE, Moris AJ, Tanner DC, Nguyen ML, Snydman DR, Wagener MM, Rinaldi MG, Yu VL (1996) The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 100:617–623
Nucci M, Spector N, Bueno A, Solza C, Perecmanis T, Bacha PC, Pulcheri W (1997) Risk factors and attributable mortality associated with superinfections in neutropenic patients with cancer. Clin Infect Dis 24:575–579
Ribeiro EL, Guimarães RI, Inácio MCC, Ferreira WM, Cardoso CG, Dias SMS, Naves LF (2004) Aspectos das leveduras de Candida vinculadas as infecções nosocomiais. NewsLab 64:106–124
Sahand IH, Moragues MD, Robert R, Quindós G, Pontón J (2006) Evaluation of Bichro-Dubli Fumouze® to distinguish Candida dubliniensis from Candida albicans. Diagn Microbiol Infect Dis 55:165–167
Sheppard DC, Souza E, Hashmi Z, Robson HG, René P (1998) Evaluation of the Auxacolor system for biochemical identification of medically important yeasts. J Clin Microbiol 36:3726–3727
Verweij PE, Breuker IM, Rijs AJ, Meis JF (1999) Comparative study of seven commercial yeast identification systems. J Clin Pathol 52:271–273
Wadlin JK, Hanko G, Stewart R, Pape J, Nachamkin I (1999) Comparison of three commercial systems for identification of yeasts commonly isolated in the clinical microbiology laboratory. J Clin Microbiol 37:1967–1970
Warren NG, Hazen KC (1995) Candida, Cryptococcus, and other yeasts of medical importance. In: Murray PR, Baron GJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of clinical microbiology, 6th edn. American Society for Microbiology, Washington DC, pp 723–737
Wingard JR (1995) Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 20:115–125